3D Cell Culture In Vitro Modeling Explores New Depths genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
Editorial Article: PARP inhibitors: A new frontier in the battle against cervical cancer
Dr. Santu Saha shares his team’s groundbreaking work to develop improved cancer treatments to avoid the potential side effects of chemotherapy
05 Feb 2021
Dr. Santu Saha, Newton International Fellow of the Academy of Medical Sciences, Newcastle University
In this exclusive interview, we hear from Dr. Santu Saha about his ongoing research into effective new ways to treat cervical cancer. Dr. Saha, a Newton International fellow of the Academy of Medical Sciences working at Newcastle University, U.K., outlines how a DNA damage response pathway inhibitor, i.e. poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi), can be used to serve as reliable cancer therapies to ameliorate cisplatin toxicity whilst also targeting hypoxic tumor cells for the treatment of cervical and other cancers, where cisplatin-based chemo-radiotherapy is the standard treatment.
Corning to highlight newest products in 3D cell culture portfolio at SLAS2021
Corning Incorporated will highlight its latest technologies that support the advancement of 3D cell culture, automation, and drug discovery at this year s virtual Society for Laboratory Automation and Screening (SLAS) conference on Jan. 25 through 27.
Now more than ever, tools used to facilitate scale-up, reproducibility, and consistency of 3D cell culture are helping enable critical research needed to solve the industry s most pressing problems.
Corning will share the newest products in its 3D cell culture portfolio, including Matrigel
® matrix-3D plates, which can provide a more consistent, ready-to-use cell culture format to support organoid and spheroid culture models and reduce workflow steps. Also featured is Corning
E-Mail
CORNING, N.Y. Corning Incorporated (NYSE: GLW) will highlight its latest technologies that support the advancement of 3D cell culture, automation, and drug discovery at this year s virtual Society for Laboratory Automation and Screening (SLAS) conference on Jan. 25 through 27.
Now more than ever, tools used to facilitate scale-up, reproducibility, and consistency of 3D cell culture are helping enable critical research needed to solve the industry s most pressing problems.
Corning will share the newest products in its 3D cell culture portfolio, including Matrigel® matrix-3D plates, which can provide a more consistent, ready-to-use cell culture format to support organoid and spheroid culture models and reduce workflow steps. Also featured is Corning® Matrigel matrix for organoid culture, a vialed solution that is validated to support growth and differentiation of organoid culture and is also qualified to form stable 3D dome structures commonly used in organoid cultu